Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage.
about
Salivary immune responses to the 7-valent pneumococcal conjugate vaccine in the first 2 years of life.Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children.Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children.Staphylococcus aureus and Streptococcus pneumoniae interaction and response to pneumococcal vaccination: Myth or reality?Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens.Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adultsNext generation protein based Streptococcus pneumoniae vaccinesStaphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design.Comparative Exoproteomics and Host Inflammatory Response in Staphylococcus aureus Skin and Soft Tissue Infections, Bacteremia, and Subclinical Colonization.Modeling Specific Antibody Responses to Natural Immunization to Predict a Correlate of Protection Against Infection Before Commencing a Clinical Vaccine Trial.Detection of Natural Antibodies and Serological Diagnosis of Pneumococcal Pneumonia Using a Bead-Based High-Throughput Assay.Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children.Microarray-based identification of human antibodies against Staphylococcus aureus antigens.Clinical characteristics of children with lower respiratory tract infections are dependent on the carriage of specific pathogens in the nasopharynx.The immunological mechanisms that control pneumococcal carriage.
P2860
Q34450459-A040B3D6-7948-474C-81FF-F027CD9A5BEBQ35531214-5CE80387-2A28-4B46-9B98-5B822C1848C9Q35915846-75487705-668D-480B-A4CC-A8398E239691Q35932254-B508DD19-27D8-4448-9A24-A46C874D5A71Q36263931-F9AF8B5F-90ED-4156-807C-361E7F05D191Q37086940-D2F6FF18-873D-44CC-BF04-0B6975D17C16Q37130191-563BC82C-F1C4-4A7D-9AB3-4A49926BF510Q38177271-C35E1973-FD38-48FD-8E1D-DD9AB87D7D83Q40028798-4F14E35B-1A2B-4D9F-8652-BC95D0B17FAAQ40053752-3F746904-68B1-41F2-9922-3D14ED23890FQ40151262-0D60A602-555C-4046-9948-15F59DCC0707Q40351344-1636EA52-97CF-48DB-9ED7-3D7A867F349DQ41486894-1E314C22-9838-4157-B6AF-4FF74C550519Q47317895-10905D13-2BAA-4DFD-A032-09395CDD342BQ48364114-3FDF8367-EF72-422D-9FE9-6CDCF08A0448
P2860
Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Nasopharyngeal colonization el ...... d risk of subsequent carriage.
@ast
Nasopharyngeal colonization el ...... d risk of subsequent carriage.
@en
type
label
Nasopharyngeal colonization el ...... d risk of subsequent carriage.
@ast
Nasopharyngeal colonization el ...... d risk of subsequent carriage.
@en
prefLabel
Nasopharyngeal colonization el ...... d risk of subsequent carriage.
@ast
Nasopharyngeal colonization el ...... d risk of subsequent carriage.
@en
P2093
P2860
P356
P1476
Nasopharyngeal colonization el ...... d risk of subsequent carriage.
@en
P2093
Corné P de Vogel
Elisabeth A M Sanders
Elske J M van Gils
Reinier H Veenhoven
Sabine M P J Prevaes
Willem J B van Wamel
P2860
P304
P356
10.1128/IAI.00037-12
P407
P577
2012-03-26T00:00:00Z